BASi Press Release April 4, 2018
BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling... Learn more»
An update of news releases from Phlebotics and other firms that relate to the need for chemical measures over time, whether at the bedside or in the central clinical laboratory. We salute those firms which have advanced therapeutic drug monitoring, electrolytes, blood gases, glucose, lactate and other time dependent markers of patient status. Phlebotics gets the sample. Many extant technologies can provide the data. Year by year the required sample volumes go down along with the time to a result and a caregiver decision.
BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling... Learn more»
Phlebotics founder Pete Kissinger comments on the distractions caused by the Theranos retail blood sampling company... Learn more»
Everything You Wanted to Know About a Career in Chemistry (But Were Afraid to Ask) Learn more»
Peter Kissinger, a professor of chemistry, is the recipient of the Outstanding Commercialization Award for Purdue University Faculty... Learn more»
Products described here are under development and do not have regulatory clearance anywhere in the world. The products described are not approved for marketing by U.S. Food and Drug Administration (FDA).
The purpose of this website is strictly informational and educational and is not intended to suggest any medical treatment and/or diagnosis.